Literature DB >> 30649270

Effect of PR interval and pacing mode on persistent atrial fibrillation incidence in dual chamber pacemaker patients: a sub-study of the international randomized MINERVA trial.

Giuseppe Boriani1, Paolo Pieragnoli2, Giovanni Luca Botto3, Helmut Puererfellner4, Lluis Mont5, Matteo Ziacchi6, Antonis S Manolis7, Michele Gulizia8, Raymond Tukkie9, Maurizio Landolina10, Giuseppe Ricciardi2, Manuele Cicconelli11, Andrea Grammatico11, Mauro Biffi6.   

Abstract

AIMS: Per standard of care, dual-chamber pacemakers are programmed in DDDR mode with fixed atrioventricular (AV) delay or with long AV delay to minimize ventricular pacing. We aimed to evaluate whether the PR interval may be a specific criterion of choice between standard DDDR, to preserve AV synchrony in long PR patients, and managed ventricular pacing (MVP), to avoid ventricular desynchronization imposed by right ventricle apical pacing, in short PR patients. METHODS AND
RESULTS: In the MINERVA trial, 1166 patients were randomized to Control DDDR, MVP, or atrial anti-tachycardia pacing plus MVP (DDDRP + MVP). We evaluated the interaction of PR interval with pacing mode by comparing the risk of atrial fibrillation (AF) longer than 7 consecutive days as a function of PR interval. Out of 906 patients with available data, the median PR interval was 180 ms. The PR interval was found to significantly (P = 0.012) interact with pacing mode for AF incidence: the risk of AF > 7 days was lower [hazard ratio (HR) 0.58, 95% confidence interval (95% CI) 0.34-0.99; P = 0.047] in patients with short PR (shorter than median PR) if programmed in MVP mode compared with DDDR mode and it was lower (HR 0.65, 95% CI 0.43-0.99; P = 0.049) in patients with long PR (equal to or longer than median PR) if programmed in DDDR mode compared with MVP.
CONCLUSION: Our data show that PR interval may be used as a selection criterion to identify the optimal physiological pacing mode. Persistent AF incidence was lower in short PR patients treated by right ventricular pacing minimization and in long PR patients treated by standard dual-chamber pacing. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atrial anti-tachycardia pacing; Atrial fibrillation; Atrioventricular interval; Managed ventricular pacing; PR interval; Pacemaker; Physiological pacing; Reactive ATP™

Year:  2019        PMID: 30649270     DOI: 10.1093/europace/euy286

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  3 in total

Review 1.  Programming Pacemakers to Reduce and Terminate Atrial Fibrillation.

Authors:  Margarida Pujol-López; Rodolfo San Antonio; José María Tolosana; Lluís Mont
Journal:  Curr Cardiol Rep       Date:  2019-09-13       Impact factor: 2.931

2.  Physiologic heart rate dependency of the PQ interval and its sex differences.

Authors:  Ondřej Toman; Katerina Hnatkova; Peter Smetana; Katharina M Huster; Martina Šišáková; Petra Barthel; Tomáš Novotný; Georg Schmidt; Marek Malik
Journal:  Sci Rep       Date:  2020-02-13       Impact factor: 4.379

3.  The Use of Novel Non-Vitamin K Antagonist Oral Anticoagulants Following Closure of the Left Atrial Appendage: Preliminary Results of Clinical Follow-Up.

Authors:  Jing Zhu; Jian Xu
Journal:  Drug Des Devel Ther       Date:  2021-03-09       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.